Vault-13

683 Capital Management, LLC

NEW YORK, NY · CIK 1404574 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2012 · limited liability company

As an employer

$953.5m reported value -2.8% vs Q1 2024
131positions
38.5%in top 10
21 new 28 added 41 reduced 12 sold out vs Q1 2024

Options: 2 call positions ($8.7m notional), 12 put positions ($361.1m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HILTON GRAND VACATIONS INC COM HGV HGV 1,300,675 $52.6m5.52% 5.52% AddedShares held: Q3 2023 550.0k, Q4 2023 1.1m, Q1 2024 1.2m, Q2 2024 1.3m +80.7k +80,675 6.6%
2 CAPITAL ONE FINL CORP COM COF COF 335,000 $46.4m4.86% 4.86% AddedShares held: Q3 2023 426.0k, Q4 2023 355.0k, Q1 2024 330.0k, Q2 2024 335.0k +5.0k +5,000 1.5%
3 SHARKNINJA INC COM SHS SN SN 600,000 $45.1m4.73% 4.73% ReducedShares held: Q3 2023 650.0k, Q4 2023 665.0k, Q1 2024 725.0k, Q2 2024 600.0k -125.0k -125,000 -17.2%
4 ERO COPPER CORP COM ERO ERO 2,000,000 $42.7m4.48% 4.48% ReducedShares held: Q3 2023 2.5m, Q4 2023 2.8m, Q1 2024 2.4m, Q2 2024 2.0m -425.0k -425,000 -17.5%
5 BORGWARNER INC COM BWA BWA 1,100,000 $35.5m3.72% 3.72% ReducedShares held: Q3 2023 785.0k, Q4 2023 1.4m, Q1 2024 1.3m, Q2 2024 1.1m -175.0k -175,000 -13.7%
6 CARVANA CO CL A CVNA CVNA 275,000 $35.4m3.71% 3.71% ReducedShares held: Q3 2023 50.0k, Q4 2023 385.0k, Q1 2024 330.0k, Q2 2024 275.0k -55.0k -55,000 -16.7%
7 OCCIDENTAL PETE CORP *W EXP 08/03/202 OXY.WS OXY.WS 854,600 $35.2m3.69% 3.69% UnchangedShares held: Q3 2023 854.6k, Q4 2023 854.6k, Q1 2024 854.6k, Q2 2024 854.6k
8 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 5,325,000 $26.6m2.79% 2.79% ReducedShares held: Q3 2023 5.8m, Q4 2023 5.6m, Q1 2024 5.3m, Q2 2024 5.3m -25.0k -25,000 -0.5%
9 TG THERAPEUTICS INC COM TGTX TGTX 1,400,000 $24.9m2.61% 2.61% ReducedShares held: Q3 2023 1.4m, Q4 2023 1.7m, Q1 2024 1.6m, Q2 2024 1.4m -225.0k -225,000 -13.8%
10 BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 · principal BBIO 2.5 03.15.27 · principal BBIO 2.5 03.15.27 23,250,000 $23.2m2.43% 2.43% AddedPrincipal held: Q3 2023 14.8m, Q4 2023 14.8m, Q1 2024 17.2m, Q2 2024 23.2m +6.0m +6,000,000 34.8%
11 INSMED INC NOTE 0.750% 6/0 · principal INSM 0.75 06.01.28 · principal INSM 0.75 06.01.28 10,428,000 $22.1m2.32% 2.32% NewPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 10.4m
12 COGENT COMMUNICATIONS HLDGS COM NEW CCOI CCOI 375,000 $21.2m2.22% 2.22% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 215.0k, Q2 2024 375.0k +160.0k +160,000 74.4%
13 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 604,449 $20.9m2.20% 2.20% ReducedShares held: Q3 2023 732.8k, Q4 2023 715.0k, Q1 2024 700.0k, Q2 2024 604.4k -95.6k -95,551 -13.7%
14 XENIA HOTELS & RESORTS INC COM XHR XHR 1,325,000 $19.0m1.99% 1.99% ReducedShares held: Q3 2023 1.6m, Q4 2023 1.6m, Q1 2024 1.4m, Q2 2024 1.3m -80.0k -80,000 -5.7%
15 VIKING THERAPEUTICS INC COM VKTX VKTX 340,000 $18.0m1.89% 1.89% ReducedShares held: Q3 2023 625.0k, Q4 2023 620.0k, Q1 2024 355.0k, Q2 2024 340.0k -15.0k -15,000 -4.2%
16 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 5,000,000 $18.0m1.89% 1.89% ReducedShares held: Q3 2023 6.0m, Q4 2023 6.2m, Q1 2024 5.8m, Q2 2024 5.0m -750.0k -750,000 -13.0%
17 CARDLYTICS INC COM COM 2,100,000 $17.2m1.81% 1.81% AddedShares held: Q3 2023 1.8m, Q4 2023 1.5m, Q1 2024 2.0m, Q2 2024 2.1m +102.6k +102,600 5.1%
18 ITEOS THERAPEUTICS INC COM ITOS ITOS 1,115,000 $16.5m1.74% 1.74% AddedShares held: Q3 2023 810.0k, Q4 2023 715.0k, Q1 2024 715.0k, Q2 2024 1.1m +400.0k +400,000 55.9%
19 INSPIRED ENTMT INC COM INSE INSE 1,785,000 $16.3m1.71% 1.71% ReducedShares held: Q3 2023 1.7m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 1.8m -18.3k -18,253 -1.0%
20 LENNAR CORP CL B LEN.B LEN.B 115,000 $16.0m1.68% 1.68% UnchangedShares held: Q3 2023 225.0k, Q4 2023 155.0k, Q1 2024 115.0k, Q2 2024 115.0k
21 CAESARS ENTERTAINMENT INC NE COM CZR CZR 400,000 $15.9m1.67% 1.67% AddedShares held: Q3 2023 375.0k, Q4 2023 310.0k, Q1 2024 345.0k, Q2 2024 400.0k +55.0k +55,000 15.9%
22 PHILIP MORRIS INTL INC COM PM PM 150,000 $15.2m1.59% 1.59% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 150.0k
23 IRSA INVERSIONES Y REP S A SPON GDS ECH 10 IRS IRS 1,655,000 $14.8m1.56% 1.56% ReducedShares held: Q3 2023 0, Q4 2023 2.2m, Q1 2024 1.8m, Q2 2024 1.7m -175.0k -175,000 -9.6%
24 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,400,000 $14.4m1.51% 1.51% ReducedShares held: Q3 2023 1.1m, Q4 2023 1.3m, Q1 2024 1.6m, Q2 2024 1.4m -250.0k -250,000 -15.2%
25 KNOT OFFSHORE PARTNERS LP COM UNITS KNOP KNOP 1,570,000 $13.8m1.44% 1.44% AddedShares held: Q3 2023 1.1m, Q4 2023 1.2m, Q1 2024 1.5m, Q2 2024 1.6m +70.0k +70,000 4.7%
26 GXO LOGISTICS INCORPORATED COMMON STOCK GXO GXO 250,000 $12.6m1.32% 1.32% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 250.0k
27 RYDER SYS INC COM R R 100,000 $12.4m1.30% 1.30% ReducedShares held: Q3 2023 250.0k, Q4 2023 195.0k, Q1 2024 195.0k, Q2 2024 100.0k -95.0k -95,000 -48.7%
28 CITIGROUP INC COM NEW C C 192,500 $12.2m1.28% 1.28% ReducedShares held: Q3 2023 228.0k, Q4 2023 300.0k, Q1 2024 280.0k, Q2 2024 192.5k -87.5k -87,500 -31.2%
29 SEA LTD SPONSORD ADS SE SE 170,000 $12.1m1.27% 1.27% ReducedShares held: Q3 2023 200.0k, Q4 2023 200.0k, Q1 2024 180.0k, Q2 2024 170.0k -10.0k -10,000 -5.6%
30 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,500,000 $12.0m1.26% 1.26% AddedShares held: Q3 2023 2.0m, Q4 2023 1.8m, Q1 2024 1.2m, Q2 2024 1.5m +275.0k +275,000 22.4%
31 ALIBABA GROUP HLDG LTD SPONSORED ADS BABA BABA 165,200 $11.9m1.25% 1.25% UnchangedShares held: Q3 2023 65.0k, Q4 2023 0, Q1 2024 165.2k, Q2 2024 165.2k
32 MEIRAGTX HLDGS PLC COM MGTX MGTX 2,500,000 $10.5m1.10% 1.10% UnchangedShares held: Q3 2023 2.5m, Q4 2023 2.5m, Q1 2024 2.5m, Q2 2024 2.5m
33 VALARIS LTD CL A VAL VAL 135,000 $10.1m1.05% 1.05% ReducedShares held: Q3 2023 215.0k, Q4 2023 175.0k, Q1 2024 195.0k, Q2 2024 135.0k -60.0k -60,000 -30.8%
34 SAREPTA THERAPEUTICS INC COM SRPT SRPT 63,500 $10.0m1.05% 1.05% AddedShares held: Q3 2023 20.0k, Q4 2023 86.6k, Q1 2024 62.8k, Q2 2024 63.5k +671 +671 1.1%
35 IMMATICS N.V SHS IMTX IMTX 815,000 $9.5m0.99% 0.99% ReducedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 900.0k, Q2 2024 815.0k -85.0k -85,000 -9.4%
36 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 295,000 $8.9m0.93% 0.93% UnchangedShares held: Q3 2023 350.0k, Q4 2023 325.0k, Q1 2024 295.0k, Q2 2024 295.0k
37 WESTERN ALLIANCE BANCORP COM WAL WAL 140,000 $8.8m0.92% 0.92% ReducedShares held: Q3 2023 250.0k, Q4 2023 300.0k, Q1 2024 200.0k, Q2 2024 140.0k -60.0k -60,000 -30.0%
38 UNIQURE NV SHS QURE QURE 1,900,000 $8.5m0.89% 0.89% ReducedShares held: Q3 2023 1.6m, Q4 2023 1.7m, Q1 2024 2.0m, Q2 2024 1.9m -75.0k -75,000 -3.8%
39 HOWARD HUGHES HOLDINGS INC COM HHH HHH 125,000 $8.1m0.85% 0.85% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 125.0k
40 RXO INC COMMON STOCK RXO RXO 290,000 $7.6m0.80% 0.80% ReducedShares held: Q3 2023 650.0k, Q4 2023 590.0k, Q1 2024 500.0k, Q2 2024 290.0k -210.0k -210,000 -42.0%
41 APELLIS PHARMACEUTICALS INC COM APLS APLS 186,000 $7.1m0.75% 0.75% ReducedShares held: Q3 2023 240.0k, Q4 2023 130.0k, Q1 2024 215.0k, Q2 2024 186.0k -29.0k -29,000 -13.5%
42 ARIS MNG CORP COM ARIS ARIS 1,875,000 $7.1m0.74% 0.74% ReducedShares held: Q3 2023 2.3m, Q4 2023 1.9m, Q1 2024 1.9m, Q2 2024 1.9m -50.0k -50,000 -2.6%
43 GOSSAMER BIO INC NOTE 5.000% 6/0 · principal GOSS 5 06.01.27 · principal GOSS 5 06.01.27 14,145,000 $7.0m0.73% 0.73% ReducedPrincipal held: Q3 2023 15.1m, Q4 2023 15.1m, Q1 2024 15.1m, Q2 2024 14.1m -1.0m -1,000,000 -6.6%
44 CRESUD S A C I F Y A SPONSORED ADR CRESY CRESY 841,000 $6.9m0.73% 0.73% ReducedShares held: Q3 2023 1.4m, Q4 2023 865.9k, Q1 2024 877.0k, Q2 2024 841.0k -36.0k -35,988 -4.1%
45 ISHARES BITCOIN TRUST ETF SHS BEN INT IBIT IBIT 200,000 $6.8m0.72% 0.72% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 125.0k, Q2 2024 200.0k +75.0k +75,000 60.0%
46 SOLVENTUM CORP COM SHS SOLV SOLV 125,000 $6.6m0.69% 0.69% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 125.0k
47 STAR BULK CARRIERS CORP. SHS PAR SBLK SBLK 235,000 $5.7m0.60% 0.60% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 200.0k, Q2 2024 235.0k +35.0k +35,000 17.5%
48 SAGE THERAPEUTICS INC COM SAGE SAGE 500,000 $5.4m0.57% 0.57% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 200.0k, Q2 2024 500.0k +300.0k +300,000 150.0%
49 GOSSAMER BIO INC COM GOSS GOSS 5,750,000 $5.2m0.54% 0.54% AddedShares held: Q3 2023 1.7m, Q4 2023 3.3m, Q1 2024 3.2m, Q2 2024 5.8m +2.5m +2,500,000 76.9%
50 CACTUS ACQUISITION CORP 1 LT CLASS A ORD CCTSF CCTSF 450,000 $5.1m0.54% 0.54% UnchangedShares held: Q3 2023 450.0k, Q4 2023 450.0k, Q1 2024 450.0k, Q2 2024 450.0k
51 BRIDGEBIO PHARMA INC COM BBIO BBIO 200,000 $5.1m0.53% 0.53% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 90.0k, Q2 2024 200.0k +110.0k +110,000 122.2%
52 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 500,000 $5.0m0.53% 0.53% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 500.0k
53 ADECOAGRO S A COM AGRO AGRO 500,000 $4.9m0.51% 0.51% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 500.0k
54 VIGIL NEUROSCIENCE INC COM VIGL VIGL 1,100,000 $4.4m0.46% 0.46% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 994.9k, Q2 2024 1.1m +105.1k +105,100 10.6%
55 ROIVANT SCIENCES LTD SHS ROIV ROIV 410,000 $4.3m0.45% 0.45% AddedShares held: Q3 2023 0, Q4 2023 261.0k, Q1 2024 270.1k, Q2 2024 410.0k +139.9k +139,866 51.8%
56 INVIVYD INC COM IVVD IVVD 3,625,000 $4.0m0.42% 0.42% AddedShares held: Q3 2023 4.0m, Q4 2023 3.6m, Q1 2024 3.5m, Q2 2024 3.6m +150.0k +150,000 4.3%
57 ZEVRA THERAPEUTICS INC COM NEW ZVRA ZVRA 800,000 $3.9m0.41% 0.41% UnchangedShares held: Q3 2023 0, Q4 2023 540.8k, Q1 2024 800.0k, Q2 2024 800.0k
58 INFLARX NV COM IFRX IFRX 2,070,000 $3.6m0.38% 0.38% AddedShares held: Q3 2023 2.4m, Q4 2023 870.0k, Q1 2024 870.0k, Q2 2024 2.1m +1.2m +1,200,000 137.9%
59 AFFIMED N V ORDINARY SHS NEW AFMDQ AFMDQ 650,000 $3.5m0.37% 0.37% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 670.0k, Q2 2024 650.0k -20.0k -19,998 -3.0%
60 MODERNA INC COM MRNA MRNA 28,629 $3.4m0.36% 0.36% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 28.6k
61 IRSA INVERSIONES Y REP S A *W EXP 05/12/202 *W EXP 05/12/202 4,671,470 $3.4m0.35% 0.35% ReducedShares held: Q3 2023 1.6m, Q4 2023 3.1m, Q1 2024 5.7m, Q2 2024 4.7m -1.0m -1,012,282 -17.8%
62 XERIS BIOPHARMA HOLDINGS INC NOTE 5.000% 7/1 · principal XERS 5 07.15.25 · principal XERS 5 07.15.25 3,200,000 $3.2m0.34% 0.34% UnchangedPrincipal held: Q3 2023 3.0m, Q4 2023 3.0m, Q1 2024 3.2m, Q2 2024 3.2m
63 BRITISH AMERN TOB PLC SPONSORED ADR BTI BTI 100,000 $3.1m0.32% 0.32% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
64 STANDARD BIOTOOLS INC NOTE 5.250%12/0 · principal LAB 5.25 12.01.24 · principal LAB 5.25 12.01.24 3,000,000 $3.0m0.32% 0.32% NewPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.0m
65 SOLENO THERAPEUTICS INC COM SLNO SLNO 70,000 $2.9m0.30% 0.30% ReducedShares held: Q3 2023 87.0k, Q4 2023 87.0k, Q1 2024 78.0k, Q2 2024 70.0k -8.0k -8,000 -10.3%
66 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 1,501,871 $2.9m0.30% 0.30% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.5m
67 SMARTRENT INC COM CL A SMRT SMRT 1,107,569 $2.6m0.28% 0.28% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 745.8k, Q2 2024 1.1m +361.7k +361,721 48.5%
68 FRACTYL HEALTH INC COM COM 643,000 $2.6m0.28% 0.28% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 750.0k, Q2 2024 643.0k -107.0k -107,000 -14.3%
69 BAIDU INC SPON ADR REP A BIDU BIDU 30,000 $2.6m0.27% 0.27% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 20.0k, Q2 2024 30.0k +10.0k +10,000 50.0%
70 LEAP THERAPEUTICS INC COM NEW CYPH CYPH 1,300,000 $2.5m0.27% 0.27% AddedShares held: Q3 2023 490.0k, Q4 2023 450.0k, Q1 2024 450.0k, Q2 2024 1.3m +850.0k +850,000 188.9%
71 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 600,000 $2.5m0.27% 0.27% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 600.0k
72 MODULAR MED INC COM NEW COM NEW 1,525,000 $2.4m0.25% 0.25% ReducedShares held: Q3 2023 939.0k, Q4 2023 939.0k, Q1 2024 1.5m, Q2 2024 1.5m -22.3k -22,300 -1.4%
73 ISHARES SILVER TR ISHARES SLV SLV 90,000 $2.4m0.25% 0.25% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 90.0k
74 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 400,000 $2.3m0.24% 0.24% ReducedShares held: Q3 2023 0, Q4 2023 220.0k, Q1 2024 615.0k, Q2 2024 400.0k -215.0k -215,000 -35.0%
75 HUDSON TECHNOLOGIES INC COM HDSN HDSN 250,563 $2.2m0.23% 0.23% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 250.6k
76 GLOBALSTAR INC COM COM 1,950,000 $2.2m0.23% 0.23% AddedShares held: Q3 2023 2.0m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.9m +215.8k +215,805 12.4%
77 HILLEVAX INC COM COM 140,000 $2.0m0.21% 0.21% AddedShares held: Q3 2023 121.2k, Q4 2023 121.2k, Q1 2024 113.0k, Q2 2024 140.0k +27.0k +27,000 23.9%
78 FIBROGEN INC COM COM 2,150,000 $1.9m0.20% 0.20% AddedShares held: Q3 2023 0, Q4 2023 700.3k, Q1 2024 1.9m, Q2 2024 2.1m +300.0k +300,000 16.2%
79 KAROOOOO LTD ORD SHS KARO KARO 65,091 $1.9m0.20% 0.20% ReducedShares held: Q3 2023 64.0k, Q4 2023 65.6k, Q1 2024 65.6k, Q2 2024 65.1k -500 -500 -0.8%
80 GALAPAGOS NV SPON ADR LKFT LKFT 70,000 $1.7m0.18% 0.18% AddedShares held: Q3 2023 58.0k, Q4 2023 58.0k, Q1 2024 58.0k, Q2 2024 70.0k +12.0k +12,000 20.7%
81 LENDINGCLUB CORP COM NEW HAPN HAPN 201,400 $1.7m0.18% 0.18% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 201.4k, Q2 2024 201.4k
82 GOLAR LNG LTD SHS GLNG GLNG 50,000 $1.6m0.16% 0.16% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 50.0k, Q2 2024 50.0k
83 MIRUM PHARMACEUTICALS INC NOTE 4.000% 5/0 · principal MIRM 4 05.01.29 · principal MIRM 4 05.01.29 1,000,000 $1.4m0.14% 0.14% NewPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.0m
84 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 600,000 $1.2m0.13% 0.13% AddedShares held: Q3 2023 508.2k, Q4 2023 115.0k, Q1 2024 115.0k, Q2 2024 600.0k +485.0k +485,000 421.7%
85 CRESUD S A C I F Y A *W EXP 03/09/202 *W EXP 03/09/202 2,372,604 $1.2m0.13% 0.13% AddedShares held: Q3 2023 1.9m, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 2.4m +323.6k +323,644 15.8%
86 SOTERA HEALTH CO COM SHC SHC 100,000 $1.2m0.12% 0.12% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
87 PAN AMERN SILVER CORP COM PAAS PAAS 50,000 $994.0k0.10% 0.10% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 50.0k
88 PONCE FINANCIAL GROUP INC COMMON STOCK PDLB PDLB 106,137 $970.1k0.10% 0.10% UnchangedShares held: Q3 2023 106.1k, Q4 2023 106.1k, Q1 2024 106.1k, Q2 2024 106.1k
89 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 348,133 $964.3k0.10% 0.10% ReducedShares held: Q3 2023 420.0k, Q4 2023 420.0k, Q1 2024 420.0k, Q2 2024 348.1k -71.9k -71,867 -17.1%
90 CARDLYTICS INC NOTE 1.000% 9/1 · principal CDLX 1 09.15.25 · principal CDLX 1 09.15.25 1,000,000 $917.5k0.10% 0.10% UnchangedPrincipal held: Q3 2023 16.0m, Q4 2023 19.0m, Q1 2024 1.0m, Q2 2024 1.0m
91 IMMUNIC INC COM COM 699,301 $776.2k0.08% 0.08% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 699.3k, Q2 2024 699.3k
92 IN8BIO INC COM INAB INAB 590,811 $500.1k0.05% 0.05% ReducedShares held: Q3 2023 0, Q4 2023 614.8k, Q1 2024 614.8k, Q2 2024 590.8k -23.9k -23,943 -3.9%
93 CORE SCIENTIFIC INC NEW COM CORZ CORZ 50,000 $465.0k0.05% 0.05% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 50.0k
94 GCT SEMICONDUCTOR HLDG INC COMMON STOCK GCTS GCTS 100,000 $391.0k0.04% 0.04% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 127.0k, Q2 2024 100.0k -27.0k -26,988 -21.2%
95 METALLA RTY & STREAMING LTD COM NEW MTA MTA 109,080 $303.0k0.03% 0.03% UnchangedShares held: Q3 2023 0, Q4 2023 109.1k, Q1 2024 109.1k, Q2 2024 109.1k
96 GCT SEMICONDUCTOR HLDG INC *W EXP 03/01/202 GCTS.WS GCTS.WS 1,348,983 $202.3k0.02% 0.02% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.4m, Q2 2024 1.3m -76.0k -76,017 -5.3%
97 AADI BIOSCIENCE INC COM WHWK WHWK 80,000 $116.8k0.01% 0.01% ReducedShares held: Q3 2023 0, Q4 2023 200.0k, Q1 2024 200.0k, Q2 2024 80.0k -120.0k -120,000 -60.0%
98 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 608,683 $97.4k0.01% 0.01% ReducedShares held: Q3 2023 835.3k, Q4 2023 835.3k, Q1 2024 610.7k, Q2 2024 608.7k -2.0k -2,040 -0.3%
99 CONCORD ACQUISITION CORP II *W EXP 99/99/999 CNDAW CNDAW 825,000 $90.8k0.01% 0.01% UnchangedShares held: Q3 2023 825.0k, Q4 2023 825.0k, Q1 2024 825.0k, Q2 2024 825.0k
100 CRIXUS BH3 ACQUISITION CO *W EXP 10/04/202 *W EXP 10/04/202 990,000 $77.2k0.01% 0.01% UnchangedShares held: Q3 2023 990.0k, Q4 2023 990.0k, Q1 2024 990.0k, Q2 2024 990.0k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
ALPHABET INC GOOGL GOOGL 150,000 $22.6m150.0k shares
ENOVA INTL INC ENVA ENVA 140,000 $8.8m140.0k shares
TESLA INC TSLA TSLA 39,500 $6.9m39.5k shares
QUIDELORTHO CORP QDEL QDEL 89,201 $4.3m89.2k shares
DISCOVER FINL SVCS DFS DFS 20,000 $2.6m20.0k shares
APPLE INC AAPL AAPL 6,000 $1.0m6.0k shares
FENNEC PHARMACEUTICALS INC FENC FENC 48,108 $535.0k48.1k shares
NEW YORK CMNTY CAP TR V FLG 6 11.01.51 FLG 6 11.01.51 7,271 $238.7k7.3k shares
EIGER BIOPHARMACEUTICALS INC CLDN CLDN 29,660 $148.4k29.7k shares
KEYARCH ACQUISITION CORP 350,000 $87.5k350.0k shares
AETHERIUM ACQUISITION CORP 400,000 $23.9k400.0k shares
KEYARCH ACQUISITION CORP 175,000 $9.1k175.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ELI LILLY & CO LLY · Put LLYPut 191,000 $172.9m191.0k shares Added
TESLA INC TSLA · Put TSLAPut 363,000 $71.8m363.0k shares Reduced
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 122,900 $29.9m122.9k shares Added
MODERNA INC MRNA · Put MRNAPut 242,000 $28.7m242.0k shares New
CAPITAL ONE FINL CORP COF · Put COFPut 100,000 $13.8m100.0k shares Unchanged
COINBASE GLOBAL INC COIN · Put COINPut 50,000 $11.1m50.0k shares Reduced
WD 40 CO WDFC · Put WDFCPut 50,000 $11.0m50.0k shares Unchanged
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 200,000 $7.7m200.0k shares New
ALPHABET INC GOOG · Put GOOGPut 30,000 $5.5m30.0k shares Reduced
CHARLES RIV LABS INTL INC CRL · Put CRLPut 25,000 $5.2m25.0k shares New
CAESARS ENTERTAINMENT INC NE CZR · Put CZRPut 100,000 $4.0m100.0k shares New
GE HEALTHCARE TECHNOLOGIES I GEHC · Put GEHCPut 50,000 $3.9m50.0k shares Unchanged
MADRIGAL PHARMACEUTICALS INC MDGL · Put MDGLPut 11,500 $3.2m11.5k shares Reduced
TESLA INC TSLA · Call TSLACall 5,000 $989.4k5.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GOSSAMER BIO INC GOSS · 13G · filed 2026-06-11 GOSS 10.0%≈ $8.2m +6.1 pts 13G 2026-06-11
MEREO BIOPHARMA GROUP PLC MREO · 13G · filed 2026-01-06 MREO 8.2% new 13G 2026-01-06
IN8BIO INC INAB · 13G · filed 2025-12-30 INAB 7.9%≈ $1.1m new 13G 2025-12-30
IMMUNIC INC 13G · filed 2026-02-17 5.9% -4.0 pts 13G 2026-02-17